L Placidi

Antiviral <scp>l</scp> -Nucleosides Specific for Hepatitis B Virus Infection

Martin L. Bryant, Edward G. Bridges, L Placidi et al. · Antimicrobial Agents and Chemotherapy · 2001 · 179 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +16

Pharmacology of β- <scp>l</scp> -Thymidine and β- <scp>l</scp> -2′-Deoxycytidine in HepG2 Cells and Primary Human Hepatocytes: Relevance to Chemotherapeutic Efficacy against Hepatitis B Virus

Brenda I. Hernández-Santiago, L Placidi, E. Cretton‐Scott et al. · Antimicrobial Agents and Chemotherapy · 2002 · 52 citations · Full text

Medicine, Biochemistry, Pharmacology +11

Disposition and metabolism of the angiogenic moderator O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470) in human hepatocytes and tissue microsomes.

L Placidi, E. Cretton‐Scott, Georges de Sousa et al. · PubMed · 1995 · 40 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

Reduction of 3′-azido-3′-deoxythymidine to 3′-amino-3′-deoxythymidine in human liver microsomes and its relationship to cytochrome P450

L Placidi, E M Cretton, M. Placidi et al. · Clinical Pharmacology & Therapeutics · 1993 · 32 citations

Medicine, Biochemistry, Pharmacology +17

Pharmacokinetics and metabolism of O -(chloroacetyl-carbamoyl) fumagillol (TNP-470, AGM-1470) in rhesus monkeys

Erika Cretton-Scott, L Placidi, Harold M. McClure et al. · Cancer Chemotherapy and Pharmacology · 1996 · 28 citations

Pharmacy, Pharmacokinetics, Pharmacology +8